"Leverage the power of the immune system."

Investor & Media

Investor relations

Immage Biotherapeutics Corp., a subsidiary or PepVax, Inc., is an early-stage biotechnology company developing novel immunotherapy biologics to treat various cancers. Immage Biotherapeutics’ co-founder, Dr. Anton Dormer, is a leading expert in peptide design and protein development through computational biology, having developed bioinformatics tools for cancer drug development. Co-founder Mr. Mahesh Narayanan is an experienced entrepreneur in the field of biotechnology, leading the business development strategies for Immage Biotherapeutics.

Immage Biotherapeutics has a method that allows for the rapid development of key cancer immunotherapy candidates that could be licensed to the biotechnology and pharmaceutical industry, giving them opportunity to develop in vitro proven treatments, establishing credibility of our rapid development model.

The company is seeking financing through IPO to complete development of its lead pre-IND programs and enter Phase I clinical trials with its first therapeutic candidate.

Immage Biotherapeutics Corp. (IMMG)